日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Isofloridoside: a novel inhibitor of Streptococcus mutans biofilm formation and glucosyltransferase activity

异氟苷:一种新型的变形链球菌生物膜形成和葡萄糖基转移酶活性抑制剂

Kimijima, Manami; Narisawa, Naoki; Hama, Yoichiro; Nakagawa-Nakamura, Tomoyo; Ito, Tatsuro

Atmospheric Intermediates at the Air-Water Interface

大气中气水界面处的中间体

Enami, Shinichi; Numadate, Naoki; Hama, Tetsuya

Interleukin-34 cancels anti-tumor immunity by PARP inhibitor

白细胞介素-34通过PARP抑制剂消除抗肿瘤免疫。

Takayoshi Nakamura ,Nabeel Kajihara ,Naoki Hama ,Takuto Kobayashi ,Ryo Otsuka ,Nanumi Han ,Haruka Wada ,Yoshinori Hasegawa ,Nao Suzuki ,Ken-Ichiro Seino

An optimized protocol for patient-derived xenograft in humanized mice to evaluate the role of IL-34 in immunotherapeutic resistance

一种优化的患者来源异种移植模型方案,用于在人源化小鼠中评估IL-34在免疫治疗耐药性中的作用。

Nanumi Han ,Hye Yoon Jang ,Naoki Hama ,Takuto Kobayashi ,Ryo Otsuka ,Haruka Wada ,Ken-Ichiro Seino

Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells

溴结构域蛋白 4 调节小鼠卵巢癌细胞中的白细胞介素-34 表达

Nanumi Han #, Delnur Anwar #, Naoki Hama, Takuto Kobayashi, Hidefumi Suzuki, Hidehisa Takahashi, Haruka Wada, Ryo Otsuka, Muhammad Baghdadi, Ken-Ichiro Seino

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)

日本接受高致吐性化疗的患者中,帕洛诺司琼与格拉司琼在标准三联疗法中预防化疗引起的恶心和呕吐的经济分析(TRIPLE III期试验)

Shimizu, Hisanori; Suzuki, Kenichi; Uchikura, Takeshi; Tsuji, Daiki; Yamanaka, Takeharu; Hashimoto, Hironobu; Goto, Koichi; Matsui, Reiko; Seki, Nobuhiko; Shimada, Toshikazu; Ikeda, Shunya; Ikegami, Naoki; Hama, Toshihiro; Yamamoto, Nobuyuki; Sasaki, Tadanori

Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphoma

M-CSFR 抑制剂对成人 T 细胞白血病/淋巴瘤的潜在抗淋巴瘤作用

Yoshihiro Komohara, Osamu Noyori, Yoichi Saito, Hiroto Takeya, Muhammad Baghdadi, Fumihito Kitagawa, Naoki Hama, Kozo Ishikawa, Yutaka Okuno, Kisato Nosaka, Ken-Ichiro Seino, Masao Matsuoka, Shinya Suzu

BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer

BRCA/范康尼贫血通路与胆道癌对吉西他滨的化学耐药性有关

Shinsuke Nakashima, Shogo Kobayashi, Hiroaki Nagano, Akira Tomokuni, Yoshito Tomimaru, Tadafumi Asaoka, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Shigeru Marubashi, Hidetoshi Eguchi, Yuichiro Doki, Masaki Mori

Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer

胰腺癌患者血清中富亮氨酸α2糖蛋白-1的临床病理意义

Kenta Furukawa, Koichi Kawamoto, Hidetoshi Eguchi, Masahiro Tanemura, Tsukasa Tanida, Yoshito Tomimaru, Hirofumi Akita, Naoki Hama, Hiroshi Wada, Shogo Kobayashi, Yuji Nonaka, Shinji Takamatsu, Shinichiro Shinzaki, Takashi Kumada, Shinji Satomura, Toshifumi Ito, Satoshi Serada, Tetsuji Naka, Masaki

The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer

己糖激酶 2 和丙酮酸激酶 M2 的表达组合是胰腺癌患者的预后标志物

Hisataka Ogawa, Hiroaki Nagano, Masamitsu Konno, Hidetoshi Eguchi, Jun Koseki, Koichi Kawamoto, Naohiro Nishida, Hugh Colvin, Akira Tomokuni, Yoshito Tomimaru, Naoki Hama, Hiroshi Wada, Shigeru Marubashi, Shogo Kobayashi, Masaki Mori, Yuichiro Doki, Hideshi Ishii